Table 1 Baseline characteristics.
Brace group (n = 74) | Control group (n = 72) | P-value | |
|---|---|---|---|
Age (years), median (P25, P75) | 71.5 (56, 76) | 72 (64, 77) | 0.248 |
Gender (n), numbers (%) | |||
Male | 30 (40.5) | 25 (34.7) | 0.468 |
Female | 44 (59.5) | 47 (65.3) | |
Sheath size (Fr) (n), numbers (%) | |||
5Fr | 49 (66.2) | 53 (73.6) | 0.330 |
6Fr | 25 (33.7) | 19 (26.3) | |
Type of operation, numbers (%) | |||
Diagnostic (CAG) | 48 (64.9) | 43 (59.7) | 0.531 |
Therapeutic procedures (PCI) | 26 (35.1) | 29 (40.3) | |
Duration of operation (min), median (P25, P75) | 35 (20.0, 55.5) | 30 (22.5, 50.8) | 0.817 |
Intraoperative heparin (U), median (P25, P75) | 3000 (3000, 6000) | 3000 (3000, 5000) | 0.434 |
History of smoking, numbers (%) | |||
None | 43 (58.1) | 51 (70.8) | 0.395 |
Quit | 16 (21.6) | 9 (12.5) | |
Occasionally | 8 (10.8) | 6 (8.3) | |
Often | 7 (9.5) | 6 (8.3) | |
History of Alcohol consumption, numbers (%) | |||
None | 54 (73.0) | 53 (73.6) | 0.298 |
Quit | 7 (9.5) | 12 (16.7) | |
Occasionally | 8 (10.8) | 3 (4.2) | |
Often | 5 (6.8) | 4 (5.6) | |
Antiplatelet drugs consumption, numbers (%) | |||
None | 17 (23.0) | 13 (18.1) | 0.625 |
SAPT | 19 (25.6) | 23 (31.9) | |
DAPT | 38 (51.4) | 36 (50.0) | |
Anticoagulant medications consumption, numbers (%) | |||
None | 67 (90.5) | 67 (93.1) | 0.654 |
DOAC | 7 (9.5) | 5 (6.9) | |
DATP + DOAC, numbers (%) | 3 (4.1) | 1 (1.4) | 0.632 |
